Taxane-resistant lymphoepithelial-like carcinoma: excellent response to VIP chemotherapy.
Lymphoepithelial-like carcinoma is a rare tumour type. The optimal treatment for this disease is not known. No effective therapies are described in the literature. This report describes a case of lymphoepithelial-like carcinoma and documents a therapeutic strategy which has proved effective. The patient was initially treated with a common platinum-based chemotherapy regimen incorporating a taxane (Carbplatin and Docetaxel). Disease stabilization initially occurred but the patient soon progressed. The patient was then treated with VIP chemotherapy and had a complete response. VIP chemotherapy appears to be an effective therapeutic strategy in lymphoepithelial-like carcinoma.